InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.15
(
-0.38%
)
Bitcoin
61,050.33
(
0.39%
)
Post# of 252388
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biocqr

Send PM Follow Ignore
Followers 49
Posts 3516
Boards Moderated 0
Alias Born 08/24/2005

biocqr

Member Level

Re: DewDiligence post# 224755

Monday, 08/19/2019 7:36:19 PM

Monday, August 19, 2019 7:36:19 PM

Post# of 252388
ARWR > clinical trial listing for ARO-HBV + 2 previously undisclosed drugs...JNJ-6379 + NA

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection (REEF-1)
https://clinicaltrials.gov/ct2/show/NCT03982186

JNJ-56136379 at EASL (e472 & e473)...
https://ilc-congress.eu/wp-content/uploads/2019/04/EASL-ILC2019-AbstractBook-13042019-Final.pdf

FRI-188
Sequence analysis of baseline and on-treatment samples from
HBV-infected chronic hepatitis B patients treated for 28 days with
JNJ-56136379 monotherapy

FRI-189
HBcrAg decline in JNJ-56136379-treated chronic hepatitis B
patients: Results of a phase 1 study

ARWR Presentation...

The Science of HBV Cure 2019
http://ir.arrowheadpharma.com/static-files/d6073d43-ba9d-4f8e-b68e-9ba990e59375


Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up